Back to the Virtual Exhibit Hall

 

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to developing medicines for people with serious diseases — often with limited or no options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We are a leader in sleep disorders and epilepsy; further developing in movement disorders and PTSD; and focused on hematologic malignancies and solid tumors. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules, biologics, innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit Jazz Pharma Website and follow @JazzPharma on Twitter

ALL Product -Treatment Website

AML Product – Treatment Website

 

      

 

 

 

 

 

 

 

Erin Chenault

Senior Leukemia & Bone Marrow Transplantation Account Manager

(469) 586-8000

Erin.Chenault@jazzpharma.com

Sarah Walsh

Oncology Account Manager

sarah.walsh@jazzpharma.com

ZOOM

 

 

PDF icon ALL Treatment - Prescribing Information.pdf

PDF icon ALL Treatment - Dosing Ordering Guide.pdf

PDF icon AML Treatment - NCCN Guidelines.pdf

PDF icon AML Treatment - Dosing and Administration Information.pdf

PDF icon AML Treatment - Nurse and Pharmacist Guide.pdf